Home › Endometrial Cancer › Ohio › Parma
Endometrial Cancer clinical trials in Parma, OH
4 studies for Endometrial Cancer are looking for participants at sites in and around Parma (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
RecruitingPhase 2
- University Hospitals Parma Medical Center, Parma
- UH Seidman Cancer Center at Saint John Medical Center, Westlake · 11 mi away
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RecruitingPhase 2
- UH Seidman Cancer Center at UH Avon Health Center, Avon · 17 mi away
Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
RecruitingPhase 2
- University Hospitals Parma Medical Center, Parma
- UH Seidman Cancer Center, Westlake · 11 mi away
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
RecruitingPhase 3
- University Hospitals Parma Medical Center, Parma
- UH Seidman Cancer Center at Saint John Medical Center, Westlake · 11 mi away
Endometrial Cancer trials in other cities
- Houston, TX69 studies
- New York City, NY54 studies
- Boston, MA51 studies
- Arlington, VA41 studies
- Nashville, TN38 studies
- Los Angeles, CA35 studies
- St. Louis, MO29 studies
- Philadelphia, PA29 studies
- Oklahoma City, OK28 studies
- San Antonio, TX27 studies
- Queens, NY26 studies
- Dallas, TX25 studies
Other studies in Parma
- Ulcerative Colitis9 studies
- Steatotic Liver Disease8 studies
- Crohn's Disease6 studies
- Schizophrenia5 studies
- Lung Cancer5 studies
- Ovarian Cancer4 studies
- Alzheimer's Disease4 studies
- Psychotic Disorders4 studies
- Major Depressive Disorder4 studies
- Cancer (all types)3 studies
- Lupus3 studies
- Non-Small Cell Lung Cancer3 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.